INTRODUCTION
In 1964, Menache reported a congenital variant of fibrinogen, which she characterized as immunologically normal but nonfunctional (nonclottable) (1) . Since then, other inherited fibrinogen variants have been described (2) (3) (4) (5) (6) (7) (8) (9) , and several previous reports (10, 11) of hypofibrinogenemia are now believed to be qualita-tive rather than quantitative abnormalities. The clinical concomitants of these abnormal fibrinogens have varied greatly, ranging from no clinical symptoms to bleeding tendencies. Thrombotic problems have occasionally occurred (2, 5, 11) . In several instances, wound dehiscence occurred (1, 4) . While in most instances the functional defect has been in the polymerization phase of clot formation, in two of these variants (1, 9) , an abnormality has existed in the enzymatic conversion by thrombin of fibrinogen to fibrin monomer. Certain physicochemical changes have served to distinguish these fibrinogen variants from normal fibrinogen and from each other. We have studied a family characterized not only by the presence of a congenital fibrinogen variant (fibrinogen St. Louis) but also by factor VIII deficiency (classical hemophilia). The biochemical and biophysical properties of the abnormal fibrinogen have been compared with previously published results of other fibrinogen variants. Direct comparisons were made between fibrinogen St. Louis, the other most similar variant-fibrinogen Zurich,' and normal fibrinogen.
METHODS
Partial thromboplastin time (12) , prothrombin time (12) , thrombin time (12) , fibrinogen (13) , factors II (12) , V (12) , VII (14) , and X (12) , clot retraction (12) , platelet factor 3 release (12) , platelet adherence to glass beads (12) , and platelet aggregation (12) were performed according to previously published methods. Assays for factors VIII, IX, XI, and XII were performed by a kaolin partial thromboplastin time (15) technique with congenitally deficient substrate.
Purified fibrinogen was initially prepared as the fraction I-4 of Blomback and Blombick (16) . Because of the limited amount of plasma available from Zurich, the comparative studies between fibrinogens Zurich, St. Louis, and normal 'Kindly furnished by Dr. P. W. Straub, Zurich, Switzerland.
were carried out using purified fibrinogen obtained by the method of Straughn and Wagner (17) which yielded more fibrinogen per milliliter plasma than did the method of Blomback and Blombdck. Normal fibrinogen was prepared from the pooled plasma of four normal donors. Blood was collected as 9 vol/1 vol of chilled 0.1 M sodium oxalate. Coagulability was measured by a modification of the method of Laki (18) . After a measured volume of fibrinogen solution was clotted with thrombin at pH 6.7, the absorbance at 280 mik of the supernatant, nonclotted protein was determined. This was corrected for light scattering by subtracting from the absorbance at 280 mit, 1.7 times the absorbance of 320 mA. The absorbance of thrombin at 280 mAt was also subtracted. The corrected absorbance of the noncoagulable material was divided by the corrected absorbance value for the same amount of fibrinogen not treated with thrombin. This figure multiplied times 100 was the per cent of noncoagulable protein.
Nitrogen determinations were performed by micro-Kjeldahl procedure (19) and microninhydrin technique (20) . Carbohydrate analyses were performed as follows: (a) hexosamine, a modified Elson-Morgan method using a glucosamine hydrochloride standard (21); (b) hexose, by the phenol sulfuric method of DuBois, Gilles, Hamilton, Rebers, and Smith using a 1: 1 mixture of galactose and mannose (22) ; (c) sialic acid, by the thiobarbiturate assay method of Warren (23) . Absorbance coefficients were calculated on the basis of Kjeldahl nitrogens and absorbance readings at 280 mu of fibrinogen solutions dialyzed against phosphate-buffered saline. The readings were made on a Beckman DU spectrophotometer (Beckman Instruments, Inc., Fullerton, Calif.). Per cent nitrogen by weight was assumed to be 16.7% (24) . N-terminal amino acids were determined by a previously described modification (25) of the 5-dimethylamino-1-naphthalenesulfonyl chloride (dansyl chloride) method (26) .
The fibrinogens were reduced and alkylated by the method of Edelman (27) Repolymerization of fibrin monomer was followed in a Beckman DU spectrophotometer at 350 mu using a previously described modification (30) of the method of Latallo, Fletcher, Alkjaersig, and Sherry (32) . As repolymerization proceeds, light scattering results, thus increasing the absorbance at 350 my. The change in the 350 mju reading is a measure of the rate of polymerization. Fibrin polymerization times were performed by taking 0.20 ml of a 0.5 g/ 100 ml fibrinogen solution, 0.04 ml of a 0.5 M tris-phosphate solution (pH 4.3) and adding 0.02 ml of a 200 U/ml bovine thrombin solution. The mixtures were then incubated at 370C for 6 hr. The pH and ionic strength were then altered by adding 0.16 ml of 0.1 M sodium phosphate pH 6.4, so as to permit polymerization. The time from the addition of the sodium phosphate solution until the appearance of a visible clot was recorded as the polymerization time.
The thrombin-induced release of fibrinopeptides from normal fibrinogen and fibrinogen St. Louis was measured by the method of Gaston, Lucas, and Miller (33) as the fluorescence of the C-terminal arginine (guanidino group) in alkaline ninhydrin (34) . Bovine thrombin (Parke, Davis & Co., Detroit, Mich.) was purified by DEAE-cellulose chromatography by the method of Yin and Wessler (35) and dissolved in 0.15 M sodium chloride containing 0.1% bovine albumin (Armour Pharmaceutical Co., Chicago, Ill.). taining the complete system were similarly incubated for 2, 4, 6, 8, and 10 min. The reaction was stopped at the appropriate times by the addition of 0.5 ml of 12% TCA to all tubes except control A. The reaction mixtures were then passed through Millipore filters (13 mm, 0.8 g, AAWP 01300) using Swinnex filter supports (Millipore SX 0001-300, Millipore Corp., Bedford, Mass.). 0.18 ml of KOH (to neutralize TCA), 0.32 ml of water, 1.0 ml of 0.5% aqueous ninhydrin, and 1.0 ml of 1.0 N KOH were added to 0.5 ml of reaction mixture. After mixing, the tubes were placed in darkness for 11 min, after which the fluorescence was read in 10 X 75 mm disposable Pyrex tubes using a model 110 Turner fluorometer at 10 X using Turner filters (G. K. Turner Associates, Palo Alto, Calif.) 7-60 (excitation) and 8 (emission). Results of the coagulation studies on J. B. are summarized in Table I . The abnormal bleeding time, fibrinogen levels, and platelet counts returned to normal after a splenectomy. (A detailed description of serial coagulation studies and clinical data of J. B. during extensive abdominal surgery-portal cava shunt and splenectomy-has been published elsewhere [36] .) The half-life of plasma factor VIII after transfusion was consistent with hemophilia A rather than von Willebrand's disease. Platelet aggregation by adenosine diphosphate, thrombin, collagen, and epinephrine was normal as was platelet retention on glass beads. Other members of the family sharing the fibrinogen defect also had prolonged and 330 mi were essentially identical.
Electrophoresis. Immunoelectrophoresis (Fig. 3) , as well as the starch gel electrophoretic patterns of the reduced and alkylated fragments revealed no differences. In acrylamide gel (Fig. 4) , normal fibrinogen and fibrinogen St Louis had the same electrophoretic mobility. Fibrinogen Zurich was more heterogeneous with a broad major and distinct minor band. The noncoagulable portion of fibrinogen Zurich exhibited even more heterogeneity, with one major band and three to seven minor bands.
Immunodiffusion. On Ouchterlony analysis, normal fibrinogen, fibrinogen St. Louis, and fibrinogen Zurich all formed single lines of identity with a rabbit anti- human fibrinogen serum. However, the concentrated noncoagulable fraction of fibrinogen Zurich consisted of two distinct bands (Fig. 5) , the second of which appeared after 72 hr of incubation. DEAE chromatography. On DEAE gradient chromatography, all three preparations demonstrated the same major and minor peaks of fibrinogen (peaks 1 and peaks 2) described by Mosesson and Finlayson (38) . There were no significant differences in either the position on the gradient where the peaks appeared or in the relative amounts of fibrinogen in each peak.
Carbohydrate analysis. Results of carbohydrate analysis are summarized in Table III Fibrinopeptide release. This assay was performed once on a sample from the propositus, J. B., and on three occasions on samples from his affected son, J. B., Jr. All the runs yielded similar results. Several different normals were used. The findings on one such determination are shown in Fig. 6 . The fibrinopeptide release is expressed as relative fluorescence units. Though the rate of fibrinopeptide release from fibrinogen St. Louis was somewhat less than that released from normal fibrinogen, and was so on all four determinations, the difference may not be significant.
Amino acids. There were no significant differences between the three fibrinogens in the content of individual amino acids. In a study of acquired dysfibrinogenemia, Mester and Szabados (40) described an increase in the sialic acid to hexosamine ratio. Similar increases have been reported in fibrinogens Paris and Detroit and is present in our results with fibrinogen Zurich (Table IV) . A slight increase in this ratio has been noted in the thrombin-coagulable early derivative of plasmin-induced proteolysis of fibrinogen, both in vitro (25) and in vivo (30 
